← Back

Wire · opportunities

US FDA Grants CorTec Second Breakthrough Device Designation For Brain-Computer Interface

Published

30 August 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at insights.citeline.com

Verified

Fusion42 · 30 August 2026 · Fusion42 review

The US FDA has granted CorTec a second Breakthrough Device designation for its brain-computer interface technology, which is intended to accelerate development and review of innovative medical devices for neurological applications.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

Brain-computer interface startups like yours will face faster FDA pathways and stronger incentives to push neurological devices to market. Now is the time to align development milestones to FDA breakthrough benefits for quicker access.

Coverage

1 source · 30 Aug 2026

Related on Wire

Topics

Medtechfdabrain-computer-interfacebreakthrough-devicemedtechneurology